Eruptr

Canaccord Genuity Advises Healthcare Digital Marketing Leader Eruptr on its Sale to Amulet Capital Partners and Athyrium Capital Management

Positions Business to Meet Accelerating Demand for Tech-Enabled Marketing Initiatives to Drive Patient Acquisition and Retention in an Increasingly Digital Healthcare Ecosystem​​​​​​​   

Canaccord Genuity is pleased to announce it has advised Eruptr, an industry leader in healthcare digital marketing providing proprietary technology-enabled solutions, on its sale to Amulet Capital Partners, a middle-market private equity investment firm focused exclusively on the healthcare sector. Athyrium Capital Management, a specialized asset management company focused on opportunities in the global healthcare sector, is investing alongside Amulet. Eruptr was previously a portfolio company of H.I.G. Growth Partners.

As a growing number of patients turn to search for health-related solutions and care providers increase investment in digital marketing, Eruptr has become the leader of technology-enabled digital performance offerings. Eruptr provides end-to-end, technology-enabled healthcare digital services that allow clients to attract and retain patients and achieve marketing goals. The company offers a suite of digital marketing solutions ranging from search engine marketing to health risk assessments. Eruptr’s deep experience across critical healthcare service lines allows the company to help hospitals increase awareness and patient acquisition and achieve key performance indicators.

Since being founded in 2009, Eruptr has experienced significant growth. The company maintains direct customer relationships with blue-chip health systems, including Johns Hopkins, UNC Healthcare, Methodist, and Inova Health System, among others, and serves a client base of more than 70 systems representing in excess of 200 hospitals. Eruptr runs more than 1,000 high-impact digital marketing campaigns per month designed to target patients at the moment of intent when they are seeking treatment and appointments. The company is headquartered in Bradenton, Florida.

Amulet Capital Partners will leverage its extensive network, digital experience, and deep knowledge of the healthcare landscape to work closely with Eruptr’s existing management team to capitalize on the growing need for technology-enabled marketing and patient retention solutions. Amulet is a middle-market private equity investment firm based in Greenwich, Connecticut, focused exclusively on the healthcare sector. The firm seeks to achieve long-term capital appreciation through privately negotiated investments in healthcare companies. Amulet focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size between $50 million to $150 million.

New York-based Athyrium Capital Management is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. The firm advises funds with more than $4.6 billion in committed capital. The Athyrium team has substantial investment experience across a wide range of asset classes, including public equity, private equity, fixed income, royalties, and other structured securities. Athyrium invests across all healthcare verticals, including biopharma, medical devices and products, healthcare focused services, and healthcare information technology. The team partners with management teams to implement creative financing solutions to companies’ capital needs.

Canaccord Genuity, with a team led by Tom O’Connor, Matt Kebel, and Sanjay Chadda, served as the exclusive financial advisor to Eruptr and H.I.G. Growth Partners.